Document is current

Any future updates will be listed below

Correction: Comparative efficacy of first- versus second-line CDK4/6 Inhibition in hormone receptor-positive, HER2-negative metastatic breast cancer

Crossref DOI link: https://doi.org/10.1186/s13058-025-02154-y

Published Online: 2025-10-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark